Our product candidates provide opportunities to control and modify diseases, and strive to address the unmet medical needs of patients and their care partners.

Our Programs

We are rapidly advancing a growing pipeline of siRNA product candidates designed to precisely target and silence disease-associated genes. Our pipeline is currently focused on three principle areas of high unmet need: cardiovascular disease, iron loading anemias and complement-mediated disorders.

Picture1.png (2) Picture1.png (2)